NCT01888289View on ClinicalTrials.gov

Bioequivalence Study of Isotretinoin Capsules 40 mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

August 31, 2001

Study Completion Date

September 30, 2001

Conditions
Healthy
Interventions
DRUG

Isotretinoin

Isotretinoin Capsules,40 mg

Trial Locations (1)

27514

AAI, Quadrangle Drive, Chapel Hill,

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY